Particular areas of expertise: Project Management,
Pharmaceutical Development, QA and General Management
Ilva van Bommel studied Pharmacy at the University of Utrecht. In 1985, she started her industrial career at Solvay Duphar in Weesp, where she worked in collaboration with the University of Utrecht on the development of a gradient matrix system for oral controlled delivery of drugs. This work resulted in a thesis in 1990. She held various positions in the Pharmaceutical Development Department of Solvay Pharma Europe. At her departure, she was Head of the Department for Dosage Formulation Development.
In 1995, she joined the newly established Formulation Research and Development company, OctoPlus BV, in Leiden as Head of Pharmaceutical Development and later as Managing Director of OctoPlus Development BV. OctoPlus (EuroNext: OCTO) is dedicated to develop and produce products for the pharmaceutical and the biotechnology industry. She played an important role in the start-up, orgnaisation and growth of this company. As project leader, she was responsible for the development of various biotech (parenteral) and conventional (tablet and capsule) drug products She was responsible for the design and validation of the OctoPlus production facility in 1999 (for manufacture of clinical trial material) and the establishment of the operational department. As from 1999 Ilva van Bommel is the Qualified Person for pharmaceutical release of the finished products. These products are mostly aseptically prepared parenteral formulations. In July 2002, she changed position to become Director Quality Assurance and Regulatory Affairs of the entire OctoPlus Group.
In September 2005, she started her own consultancy company, GBP Consultancy BV. Since its start, GBP Consultancy has been participating in a wide range of projects for small- and medium sized companies (e.g., setting up GMP quality systems, re-building of GMP production areas, pharmaceutical development programs, project management, Qualified Person for clinical trial material).
Ilva van Bommel published more than 30 papers on preformulation, liposomes, oral controlled delivery, microencapsulation and pharmaceutical technology in international scientific papers. She is treasurer of the Netherlands Society of Pharmaceutical Sciences (NVFW).
